2-[2-(2-hydroxyphenyl)-3,6-diphenylimidazo[4,5-h]quinazolin-8-yl]phenol;2-[2-(2-hydroxyphenyl)-4,7-diphenylpyrimido[5,4-h]quinazolin-9-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-6-phenyl-1,3,5-triazin-2-yl]-6-phenyl-1,3,5-triazin-2-yl]phenol;2-[2-(2-hydroxyphenyl)pyrido[2,3-f]quinoxalin-9-yl]phenol;4-[2-(3-hydroxy-4-pyridinyl)pyrido[3,2-h]quinazolin-9-yl]pyridin-3-ol;platinum

C141H92N22O10Pt5 — CID 159406537

IUPAC2-[2-(2-hydroxyphenyl)-3,6-diphenylimidazo[4,5-h]quinazolin-8-yl]phenol;2-[2-(2-hydroxyphenyl)-4,7-diphenylpyrimido[5,4-h]quinazolin-9-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-6-phenyl-1,3,5-triazin-2-yl]-6-phenyl-1,3,5-triazin-2-yl]phenol;2-[2-(2-hydroxyphenyl)pyrido[2,3-f]quinoxalin-9-yl]phenol;4-[2-(3-hydroxy-4-pyridinyl)pyrido[3,2-h]quinazolin-9-yl]pyridin-3-ol;platinum
SMILESOc1ccccc1-c1ccc2ccc3ncc(-c4ccccc4O)nc3c2n1.Oc1ccccc1-c1nc(-c2ccccc2)c2ccc3c(-c4ccccc4)nc(-c4ccccc4O)nc3c2n1.Oc1ccccc1-c1nc(-c2ccccc2)c2ccc3c(nc(-c4ccccc4O)n3-c3ccccc3)c2n1.Oc1ccccc1-c1nc(-c2ccccc2)nc(-c2nc(-c3ccccc3)nc(-c3ccccc3O)n2)n1.Oc1cnccc1-c1ccc2ccc3cnc(-c4ccncc4O)nc3c2n1.[Pt].[Pt].[Pt].[Pt].[Pt]
InChIInChI=1S/C34H22N4O2.C33H22N4O2.C30H20N6O2.C23H15N3O2.C21H13N5O2.5Pt/c39-27-17-9-7-15-23(27)33-35-29(21-11-3-1-4-12-21)25-19-20-26-30(22-13-5-2-6-14-22)36-34(38-32(26)31(25)37-33)24-16-8-10-18-28(24)40;38-27-17-9-7-15-23(27)32-34-29(21-11-3-1-4-12-21)25-19-20-26-31(30(25)35-32)36-33(24-16-8-10-18-28(24)39)37(26)22-13-5-2-6-14-22;37-23-17-9-7-15-21(23)27-31-25(19-11-3-1-4-12-19)33-29(35-27)30-34-26(20-13-5-2-6-14-20)32-28(36-30)22-16-8-10-18-24(22)38;27-20-7-3-1-5-15(20)17-11-9-14-10-12-18-23(22(14)25-17)26-19(13-24-18)16-6-2-4-8-21(16)28;27-17-10-22-7-5-14(17)16-4-3-12-1-2-13-9-24-21(26-20(13)19(12)25-16)15-6-8-23-11-18(15)28;;;;;/h1-20,39-40H;1-20,38-39H;1-18,37-38H;1-13,27-28H;1-11,27-28H;;;;;
InChIKeyUQIAEOMJIYBTHW-UHFFFAOYSA-N
MW3229.82 g/mol
LogP29.46
Rot. Bonds17

About 2-[2-(2-hydroxyphenyl)-3,6-diphenylimidazo[4,5-h]quinazolin-8-yl]phenol;2-[2-(2-hydroxyphenyl)-4,7-diphenylpyrimido[5,4-h]quinazolin-9-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-6-phenyl-1,3,5-triazin-2-yl]-6-phenyl-1,3,5-triazin-2-yl]phenol;2-[2-(2-hydroxyphenyl)pyrido[2,3-f]quinoxalin-9-yl]phenol;4-[2-(3-hydroxy-4-pyridinyl)pyrido[3,2-h]quinazolin-9-yl]pyridin-3-ol;platinum

2-[2-(2-hydroxyphenyl)-3,6-diphenylimidazo[4,5-h]quinazolin-8-yl]phenol;2-[2-(2-hydroxyphenyl)-4,7-diphenylpyrimido[5,4-h]quinazolin-9-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-6-phenyl-1,3,5-triazin-2-yl]-6-phenyl-1,3,5-triazin-2-yl]phenol;2-[2-(2-hydroxyphenyl)pyrido[2,3-f]quinoxalin-9-yl]phenol;4-[2-(3-hydroxy-4-pyridinyl)pyrido[3,2-h]quinazolin-9-yl]pyridin-3-ol;platinum (PubChem CID 159406537) has the molecular formula C141H92N22O10Pt5 and a molecular weight of 3229.82 g/mol. Its IUPAC name is 2-[2-(2-hydroxyphenyl)-3,6-diphenylimidazo[4,5-h]quinazolin-8-yl]phenol;2-[2-(2-hydroxyphenyl)-4,7-diphenylpyrimido[5,4-h]quinazolin-9-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-6-phenyl-1,3,5-triazin-2-yl]-6-phenyl-1,3,5-triazin-2-yl]phenol;2-[2-(2-hydroxyphenyl)pyrido[2,3-f]quinoxalin-9-yl]phenol;4-[2-(3-hydroxy-4-pyridinyl)pyrido[3,2-h]quinazolin-9-yl]pyridin-3-ol;platinum.

Molecular Properties

Compound Name2-[2-(2-hydroxyphenyl)-3,6-diphenylimidazo[4,5-h]quinazolin-8-yl]phenol;2-[2-(2-hydroxyphenyl)-4,7-diphenylpyrimido[5,4-h]quinazolin-9-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-6-phenyl-1,3,5-triazin-2-yl]-6-phenyl-1,3,5-triazin-2-yl]phenol;2-[2-(2-hydroxyphenyl)pyrido[2,3-f]quinoxalin-9-yl]phenol;4-[2-(3-hydroxy-4-pyridinyl)pyrido[3,2-h]quinazolin-9-yl]pyridin-3-ol;platinum
PubChem CID159406537
Molecular FormulaC141H92N22O10Pt5
Molecular Weight3229.82 g/mol
Exact Mass3227.56
IUPAC Name2-[2-(2-hydroxyphenyl)-3,6-diphenylimidazo[4,5-h]quinazolin-8-yl]phenol;2-[2-(2-hydroxyphenyl)-4,7-diphenylpyrimido[5,4-h]quinazolin-9-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-6-phenyl-1,3,5-triazin-2-yl]-6-phenyl-1,3,5-triazin-2-yl]phenol;2-[2-(2-hydroxyphenyl)pyrido[2,3-f]quinoxalin-9-yl]phenol;4-[2-(3-hydroxy-4-pyridinyl)pyrido[3,2-h]quinazolin-9-yl]pyridin-3-ol;platinum
SMILESOc1ccccc1-c1ccc2ccc3ncc(-c4ccccc4O)nc3c2n1.Oc1ccccc1-c1nc(-c2ccccc2)c2ccc3c(-c4ccccc4)nc(-c4ccccc4O)nc3c2n1.Oc1ccccc1-c1nc(-c2ccccc2)c2ccc3c(nc(-c4ccccc4O)n3-c3ccccc3)c2n1.Oc1ccccc1-c1nc(-c2ccccc2)nc(-c2nc(-c3ccccc3)nc(-c3ccccc3O)n2)n1.Oc1cnccc1-c1ccc2ccc3cnc(-c4ccncc4O)nc3c2n1.[Pt].[Pt].[Pt].[Pt].[Pt]
InChIInChI=1S/C34H22N4O2.C33H22N4O2.C30H20N6O2.C23H15N3O2.C21H13N5O2.5Pt/c39-27-17-9-7-15-23(27)33-35-29(21-11-3-1-4-12-21)25-19-20-26-30(22-13-5-2-6-14-22)36-34(38-32(26)31(25)37-33)24-16-8-10-18-28(24)40;38-27-17-9-7-15-23(27)32-34-29(21-11-3-1-4-12-21)25-19-20-26-31(30(25)35-32)36-33(24-16-8-10-18-28(24)39)37(26)22-13-5-2-6-14-22;37-23-17-9-7-15-21(23)27-31-25(19-11-3-1-4-12-19)33-29(35-27)30-34-26(20-13-5-2-6-14-20)32-28(36-30)22-16-8-10-18-24(22)38;27-20-7-3-1-5-15(20)17-11-9-14-10-12-18-23(22(14)25-17)26-19(13-24-18)16-6-2-4-8-21(16)28;27-17-10-22-7-5-14(17)16-4-3-12-1-2-13-9-24-21(26-20(13)19(12)25-16)15-6-8-23-11-18(15)28;;;;;/h1-20,39-40H;1-20,38-39H;1-18,37-38H;1-13,27-28H;1-11,27-28H;;;;;
InChIKeyUQIAEOMJIYBTHW-UHFFFAOYSA-N
XLogP29.46
TPSA477.92 Ų
H-Bond Donors10
H-Bond Acceptors32
Rotatable Bonds17
Heavy Atoms178
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003229.82
LogP ≤ 529.46
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1032

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'}

Analyze 2-[2-(2-hydroxyphenyl)-3,6-diphenylimidazo[4,5-h]quinazolin-8-yl]phenol;2-[2-(2-hydroxyphenyl)-4,7-diphenylpyrimido[5,4-h]quinazolin-9-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-6-phenyl-1,3,5-triazin-2-yl]-6-phenyl-1,3,5-triazin-2-yl]phenol;2-[2-(2-hydroxyphenyl)pyrido[2,3-f]quinoxalin-9-yl]phenol;4-[2-(3-hydroxy-4-pyridinyl)pyrido[3,2-h]quinazolin-9-yl]pyridin-3-ol;platinum with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[2-(2-hydroxyphenyl)-3,6-diphenylimidazo[4,5-h]quinazolin-8-yl]phenol;2-[2-(2-hydroxyphenyl)-4,7-diphenylpyrimido[5,4-h]quinazolin-9-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-6-phenyl-1,3,5-triazin-2-yl]-6-phenyl-1,3,5-triazin-2-yl]phenol;2-[2-(2-hydroxyphenyl)pyrido[2,3-f]quinoxalin-9-yl]phenol;4-[2-(3-hydroxy-4-pyridinyl)pyrido[3,2-h]quinazolin-9-yl]pyridin-3-ol;platinum?
The IUPAC name of 2-[2-(2-hydroxyphenyl)-3,6-diphenylimidazo[4,5-h]quinazolin-8-yl]phenol;2-[2-(2-hydroxyphenyl)-4,7-diphenylpyrimido[5,4-h]quinazolin-9-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-6-phenyl-1,3,5-triazin-2-yl]-6-phenyl-1,3,5-triazin-2-yl]phenol;2-[2-(2-hydroxyphenyl)pyrido[2,3-f]quinoxalin-9-yl]phenol;4-[2-(3-hydroxy-4-pyridinyl)pyrido[3,2-h]quinazolin-9-yl]pyridin-3-ol;platinum (CID 159406537) is 2-[2-(2-hydroxyphenyl)-3,6-diphenylimidazo[4,5-h]quinazolin-8-yl]phenol;2-[2-(2-hydroxyphenyl)-4,7-diphenylpyrimido[5,4-h]quinazolin-9-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-6-phenyl-1,3,5-triazin-2-yl]-6-phenyl-1,3,5-triazin-2-yl]phenol;2-[2-(2-hydroxyphenyl)pyrido[2,3-f]quinoxalin-9-yl]phenol;4-[2-(3-hydroxy-4-pyridinyl)pyrido[3,2-h]quinazolin-9-yl]pyridin-3-ol;platinum.
What is the SMILES notation for 2-[2-(2-hydroxyphenyl)-3,6-diphenylimidazo[4,5-h]quinazolin-8-yl]phenol;2-[2-(2-hydroxyphenyl)-4,7-diphenylpyrimido[5,4-h]quinazolin-9-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-6-phenyl-1,3,5-triazin-2-yl]-6-phenyl-1,3,5-triazin-2-yl]phenol;2-[2-(2-hydroxyphenyl)pyrido[2,3-f]quinoxalin-9-yl]phenol;4-[2-(3-hydroxy-4-pyridinyl)pyrido[3,2-h]quinazolin-9-yl]pyridin-3-ol;platinum?
The canonical SMILES for 2-[2-(2-hydroxyphenyl)-3,6-diphenylimidazo[4,5-h]quinazolin-8-yl]phenol;2-[2-(2-hydroxyphenyl)-4,7-diphenylpyrimido[5,4-h]quinazolin-9-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-6-phenyl-1,3,5-triazin-2-yl]-6-phenyl-1,3,5-triazin-2-yl]phenol;2-[2-(2-hydroxyphenyl)pyrido[2,3-f]quinoxalin-9-yl]phenol;4-[2-(3-hydroxy-4-pyridinyl)pyrido[3,2-h]quinazolin-9-yl]pyridin-3-ol;platinum is Oc1ccccc1-c1ccc2ccc3ncc(-c4ccccc4O)nc3c2n1.Oc1ccccc1-c1nc(-c2ccccc2)c2ccc3c(-c4ccccc4)nc(-c4ccccc4O)nc3c2n1.Oc1ccccc1-c1nc(-c2ccccc2)c2ccc3c(nc(-c4ccccc4O)n3-c3ccccc3)c2n1.Oc1ccccc1-c1nc(-c2ccccc2)nc(-c2nc(-c3ccccc3)nc(-c3ccccc3O)n2)n1.Oc1cnccc1-c1ccc2ccc3cnc(-c4ccncc4O)nc3c2n1.[Pt].[Pt].[Pt].[Pt].[Pt].
What is the InChIKey of 2-[2-(2-hydroxyphenyl)-3,6-diphenylimidazo[4,5-h]quinazolin-8-yl]phenol;2-[2-(2-hydroxyphenyl)-4,7-diphenylpyrimido[5,4-h]quinazolin-9-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-6-phenyl-1,3,5-triazin-2-yl]-6-phenyl-1,3,5-triazin-2-yl]phenol;2-[2-(2-hydroxyphenyl)pyrido[2,3-f]quinoxalin-9-yl]phenol;4-[2-(3-hydroxy-4-pyridinyl)pyrido[3,2-h]quinazolin-9-yl]pyridin-3-ol;platinum?
The InChIKey is UQIAEOMJIYBTHW-UHFFFAOYSA-N. The full InChI is InChI=1S/C34H22N4O2.C33H22N4O2.C30H20N6O2.C23H15N3O2.C21H13N5O2.5Pt/c39-27-17-9-7-15-23(27)33-35-29(21-11-3-1-4-12-21)25-19-20-26-30(22-13-5-2-6-14-22)36-34(38-32(26)31(25)37-33)24-16-8-10-18-28(24)40;38-27-17-9-7-15-23(27)32-34-29(21-11-3-1-4-12-21)25-19-20-26-31(30(25)35-32)36-33(24-16-8-10-18-28(24)39)37(26)22-13-5-2-6-14-22;37-23-17-9-7-15-21(23)27-31-25(19-11-3-1-4-12-19)33-29(35-27)30-34-26(20-13-5-2-6-14-20)32-28(36-30)22-16-8-10-18-24(22)38;27-20-7-3-1-5-15(20)17-11-9-14-10-12-18-23(22(14)25-17)26-19(13-24-18)16-6-2-4-8-21(16)28;27-17-10-22-7-5-14(17)16-4-3-12-1-2-13-9-24-21(26-20(13)19(12)25-16)15-6-8-23-11-18(15)28;;;;;/h1-20,39-40H;1-20,38-39H;1-18,37-38H;1-13,27-28H;1-11,27-28H;;;;;.
What are the key properties of 2-[2-(2-hydroxyphenyl)-3,6-diphenylimidazo[4,5-h]quinazolin-8-yl]phenol;2-[2-(2-hydroxyphenyl)-4,7-diphenylpyrimido[5,4-h]quinazolin-9-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-6-phenyl-1,3,5-triazin-2-yl]-6-phenyl-1,3,5-triazin-2-yl]phenol;2-[2-(2-hydroxyphenyl)pyrido[2,3-f]quinoxalin-9-yl]phenol;4-[2-(3-hydroxy-4-pyridinyl)pyrido[3,2-h]quinazolin-9-yl]pyridin-3-ol;platinum?
2-[2-(2-hydroxyphenyl)-3,6-diphenylimidazo[4,5-h]quinazolin-8-yl]phenol;2-[2-(2-hydroxyphenyl)-4,7-diphenylpyrimido[5,4-h]quinazolin-9-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-6-phenyl-1,3,5-triazin-2-yl]-6-phenyl-1,3,5-triazin-2-yl]phenol;2-[2-(2-hydroxyphenyl)pyrido[2,3-f]quinoxalin-9-yl]phenol;4-[2-(3-hydroxy-4-pyridinyl)pyrido[3,2-h]quinazolin-9-yl]pyridin-3-ol;platinum has a molecular weight of 3229.82 g/mol, XLogP of 29.46, 17 rotatable bonds, 10 hydrogen bond donors, and 32 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[2-(2-hydroxyphenyl)-3,6-diphenylimidazo[4,5-h]quinazolin-8-yl]phenol;2-[2-(2-hydroxyphenyl)-4,7-diphenylpyrimido[5,4-h]quinazolin-9-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-6-phenyl-1,3,5-triazin-2-yl]-6-phenyl-1,3,5-triazin-2-yl]phenol;2-[2-(2-hydroxyphenyl)pyrido[2,3-f]quinoxalin-9-yl]phenol;4-[2-(3-hydroxy-4-pyridinyl)pyrido[3,2-h]quinazolin-9-yl]pyridin-3-ol;platinum is sourced from PubChem (CID 159406537), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).